| Company Name: | 1-800 Contacts, Incorporated | | Ticker Symbol: | CTAC | | | WWW Address: | www.1800contacts.com | | CEO: | Jonathan C. Coon | | No. of Employees: | 1,101 | | Common Issue Type: | CS | | Business Description: | The Company is a direct marketer of replacement contact lenses based in the U.S. and also conducts contact lens manufacturing, development and distribution operations in Singapore and the United Kingdom.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | - | - | 0 | 24.38 | 24.15 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 341.5 | 14.1 | -0.54 | -1.68 | 0.00 | 0.0 | 0.0 | 24.38 - 13.43 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 24.25 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 341.5 | mil |
| Latest Shares Outstanding | 14.1 | mil |
| Earnings pS (EPS) | -1.68 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 225,864 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 9.1 | mil |
| Float as % of Shares Outstanding | 64.4 | % |
| Foreign Sales | 21 | mil |
| Domestic Sales | 228 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 32.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 1.70 | % |
| Gross Profit Margin | 40.9 | % |
| EBITDA Margin | 7.1 | % |
| Pre-Tax Profit Margin | -3.9 | % |
| Assets Turnover | 2.6 | % |
| Return on Assets (ROA) | -13.9 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -21.2 | % |
| Current Ratio | 1.7 | |
| Leverage Ratio (Assets/Equity) | 1.5 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | 1.33 | $ |
| Cash pS | 0.39 | $ |
| Book-Value pS | 3.70 | $ |
| Tangible Book-Value pS | 1.97 | $ |
| Cash Flow pS | -0.19 | $ |
| Free Cash Flow pS | 0.00 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 6.55 | |
| Price/Tangible Book Ratio | 12.31 | |
| Price/Cash Flow | -127.6 | |
| Price/Free Cash Flow | 0.0 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.0 | 102 | 179 | 939 |
| 4 Weeks | 24.38 | 22.50 | 23.19 | 4.6 | 105 | 525 | 9,983 |
| 13 Weeks | 24.38 | 21.94 | 23.86 | 1.6 | 105 | 430 | 27,063 |
| 26 Weeks | 24.38 | 16.47 | 18.00 | 34.7 | 130 | 312 | 39,345 |
| 52 Weeks | 24.38 | 13.43 | 14.87 | 63.1 | 146 | 206 | 51,519 |
| YTD | 24.38 | 16.15 | - | 48.7 | 145 | 255 | 43,878 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 24.16 | 24.05 | 23.63 | 20.54 | 19.44 | -0.54 | 0.32 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 9.06 | 95.4 | 7.25 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 30.76 | NA | -13.09 |
| R&D | 0.00 | NA | 11.40 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -1.1 | 0.3 | 4.5 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.83 | 1.00 | -1.48 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 9.52 |
| Current Ratio | 1.3 |
| Quick Ratio (Acid Test) | 0.3 |
| Liquidity Ratio (Cash) | 0.10 |
| Receivables Turnover | 56.2 |
| Average Collection Period | 6 |
| Working Capital/Equity | 25.4 |
| Working Capital pS | 0.71 |
| Cash-Flow pS | -0.88 |
| Free Cash-Flow pS | -0.17 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.22 |
| Financial Leverage Ratio (Assets/Equity) | 2.7 |
| Debt Ratio | 62.5 |
| Total Debt/Equity (Gearing Ratio) | 0.98 |
| LT Debt/Equity | 0.91 |
| LT Debt/Capital Invested | 48.9 |
| LT Debt/Total Liabilities | 54.8 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 2.74 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 52.63 |
| Tobin's Q Ratio | 3.40 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 25.01 |
| Enterprise Value (EV)/Free Cash Flow | -258.22 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 12.31 |
| Price/Book Ratio - LTM | 6.55 |
| Price/Cash Flow Ratio | -127.6 |
| Price/Free Cash Flow Ratio - LTM | 0.0 |
| Price/Sales Ratio | 1.35 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | 0 |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 2.56 |
| Current Liabilities pS | 2.06 |
| Tangible Book Value pS - LTM | 1.97 |
| Book Value pS - LTM | 3.70 |
| Capital Invested pS | 5.12 |
| Cash pS - LTM | 0.39 |
| Cash Flow pS - LTM | -0.19 |
| Free Cash Flow pS - LTM | 0.00 |
| Earnings pS (EPS) | -1.68 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -0.91 |
| Free Cash Flow Margin 5YEAR AVG | -0.21 |
| Net Profit Margin | -9.0 |
| Net Profit Margin - 5YEAR AVRG. | -3.0 |
| Equity Productivity | 6.60 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 3.45 |
| Return on Capital Invested (ROCI) | -31.2 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -9.0 |
| Assets Productivity | 2.30 |
| Return on Assets (ROA) | -22.3 |
| Return on Assets (ROA) - 5YEAR AVRG. | -6.6 |
| Gross Profit Margin | 40.9 |
| Gross Profit Margin - 5YEAR AVRG. | 39.9 |
| EBITDA Margin - LTM | 7.1 |
| EBIT Margin - LTM | -3.1 |
| Pre-Tax Profit Margin | -5.0 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -0.6 |
| Effective Tax Rate | -79.6 |
| Effective Tax Rate - 5YEAR AVRG. | -948.5 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 64 |
| Revenue per Employee | 225,864 |
| Net Income per Employee | -20,399 |
| Average Collection Period | 8 |
| Receivables Turnover | 56.2 |
| Day's Inventory Turnover Ratio | 56 |
| Inventory Turnover | 6.4 |
| Inventory/Sales | 9.8 |
| Accounts Payble/Sales | 4.35 |
| Assets/Revenue | 0.43 |
| Net Working Capital Turnover | 25.98 |
| Fixed Assets Turnover | 3.92 |
| Total Assets Turnover | 2.3 |
| Revenue per $ Cash | 90.86 |
| Revenue per $ Plant | 9.02 |
| Revenue per $ Common Equity | 6.60 |
| Revenue per $ Capital Invested | 3.45 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 32.2 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 32.3 |
| Research & Devlopment (R&D) as % of Revenue | 2.4 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 2.4 |
|
|  
|
| |
 |  |